Asthma Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Asthma stocks.

Asthma Stocks Recent News

Date Stock Title
Jun 24 TEVA Teva launches authorized generic of Victoza for diabetes, cardiovascular treatment in the U.S.
Jun 24 TEVA Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States
Jun 24 TEVA Here's Why You Should Consider Buying Alvotech (ALVO) Stock
Jun 24 VRNA 5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
Jun 24 REGN 5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
Jun 24 REGN Pipeline Moves: Approval prospects for BioTissue’s diabetic foot ulcer drug up after Phase III completion
Jun 22 TEVA Did Teva Pharmaceutical Industries Limited (TEVA)’s “Pivot to Growth” Strategy Help It Get a Positive Rating from Analysts?
Jun 22 AZN 3 No-Brainer Stocks to Buy for Under $100 Right Now
Jun 21 ATR Are Analysts Optimistic About AptarGroup Inc. (ATR)’s Long-term Potential?
Jun 21 AZN Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
Jun 21 REGN Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
Jun 21 AZN Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Jun 21 INVA Innoviva: Potentially Overvalued
Jun 21 AZN AstraZeneca’s Truqap and Faslodex combo receives approval in EU
Jun 20 REGN Regeneron (NASDAQ:REGN): Is This Stock-Split Contender a Strong Buy?
Jun 20 VRNA Verona Pharma: Next Week's PDUFA Date Ought To Provide An Upside Catalyst
Jun 20 AZN AstraZeneca's (AZN) Truqap Gets EU Nod for Breast Cancer
Jun 20 AZN Why Wall Street Is Chasing Ozempic Wannabes
Jun 19 ATR With EPS Growth And More, AptarGroup (NYSE:ATR) Makes An Interesting Case
Jun 19 AZN AstraZeneca’s Truqap flops in Phase III triple negative breast cancer trial
Asthma

Asthma is a common long-term inflammatory disease of the airways of the lungs. It is characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm. Symptoms include episodes of wheezing, coughing, chest tightness, and shortness of breath. These episodes may occur a few times a day or a few times per week. Depending on the person, they may become worse at night or with exercise.Asthma is thought to be caused by a combination of genetic and environmental factors. Environmental factors include exposure to air pollution and allergens. Other potential triggers include medications such as aspirin and beta blockers. Diagnosis is usually based on the pattern of symptoms, response to therapy over time, and spirometry. Asthma is classified according to the frequency of symptoms, forced expiratory volume in one second (FEV1), and peak expiratory flow rate. It may also be classified as atopic or non-atopic, where atopy refers to a predisposition toward developing a type 1 hypersensitivity reaction.There is no cure for asthma. Symptoms can be prevented by avoiding triggers, such as allergens and irritants, and by the use of inhaled corticosteroids. Long-acting beta agonists (LABA) or antileukotriene agents may be used in addition to inhaled corticosteroids if asthma symptoms remain uncontrolled. Treatment of rapidly worsening symptoms is usually with an inhaled short-acting beta-2 agonist such as salbutamol and corticosteroids taken by mouth. In very severe cases, intravenous corticosteroids, magnesium sulfate, and hospitalization may be required.In 2015, 358 million people globally had asthma, up from 183 million in 1990. It caused about 397,100 deaths in 2015, most of which occurred in the developing world. It often begins in childhood. The rates of asthma have increased significantly since the 1960s. Asthma was recognized as early as Ancient Egypt. The word "asthma" is from the Greek ἅσθμα, ásthma, which means "panting".

Browse All Tags